KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Receivables (2016 - 2025)

Historic Receivables for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $427.4 million.

  • Medpace Holdings' Receivables rose 4163.16% to $427.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $427.4 million, marking a year-over-year increase of 4163.16%. This contributed to the annual value of $427.4 million for FY2025, which is 4163.16% up from last year.
  • Latest data reveals that Medpace Holdings reported Receivables of $427.4 million as of Q4 2025, which was up 4163.16% from $383.8 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Receivables peaked at $427.4 million during Q4 2025, and registered a low of $188.4 million during Q1 2021.
  • Its 5-year average for Receivables is $296.3 million, with a median of $300.7 million in 2023.
  • As far as peak fluctuations go, Medpace Holdings' Receivables crashed by 594.78% in 2024, and later soared by 4163.16% in 2025.
  • Over the past 5 years, Medpace Holdings' Receivables (Quarter) stood at $222.5 million in 2021, then surged by 32.03% to $293.8 million in 2022, then grew by 9.21% to $320.9 million in 2023, then fell by 5.95% to $301.8 million in 2024, then skyrocketed by 41.63% to $427.4 million in 2025.
  • Its Receivables stands at $427.4 million for Q4 2025, versus $383.8 million for Q3 2025 and $383.9 million for Q2 2025.